BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38653067)

  • 21. Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors.
    Le Darz A; Mingot A; Bouazza F; Castelli U; Karam O; Tanc M; Supuran CT; Thibaudeau S
    J Enzyme Inhib Med Chem; 2015; 30(5):737-45. PubMed ID: 25431145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors.
    Moi D; Nocentini A; Deplano A; Osman SM; AlOthman ZA; Piras V; Balboni G; Supuran CT; Onnis V
    Bioorg Chem; 2020 May; 98():103728. PubMed ID: 32182519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, Molecular Docking Analysis, and Carbonic Anhydrase Inhibitory Evaluations of Benzenesulfonamide Derivatives Containing Thiazolidinone.
    Zhang ZP; Yin ZF; Li JY; Wang ZP; Wu QJ; Wang J; Liu Y; Cheng MS
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31262068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase.
    Kakakhan C; Türkeş C; Güleç Ö; Demir Y; Arslan M; Özkemahlı G; Beydemir Ş
    Bioorg Med Chem; 2023 Jan; 77():117111. PubMed ID: 36463726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors.
    Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Petreni A; Allam RM; El Diwani HI; Supuran CT
    Eur J Med Chem; 2022 Jan; 228():114004. PubMed ID: 34847409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes.
    Sharma V; Kumar R; Angeli A; Supuran CT; Sharma PK
    Eur J Med Chem; 2020 May; 193():112219. PubMed ID: 32203788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
    Soliman AM; Ghorab MM; Bua S; Supuran CT
    Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors.
    Tugrak M; Gul HI; Demir Y; Gulcin I
    Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000230. PubMed ID: 33043495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
    Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
    Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
    Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2018 Sep; 157():28-36. PubMed ID: 30071407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.
    Bozdag M; Alafeefy AM; Carta F; Ceruso M; Al-Tamimi AS; Al-Kahtani AA; Alasmary FAS; Supuran CT
    Bioorg Med Chem; 2016 Sep; 24(18):4100-4107. PubMed ID: 27396930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives.
    Abdel-Aziz AA; El-Azab AS; Bua S; Nocentini A; Abu El-Enin MA; Alanazi MM; AlSaif NA; Hefnawy MM; Supuran CT
    Bioorg Chem; 2019 Jun; 87():425-431. PubMed ID: 30921744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
    Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
    Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.